| References |
| Antibody responses to SARS-CoV-2 in patients with
COVID-19 |
| Early Transmission
Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia |
| Estimating clinical severity of COVID-19 from the
transmission dynamics in Wuhan, China |
| Evolutionary history, potential intermediate animal host,
and cross‐species analyses of SARS‐CoV‐2 |
| Exposure to air pollution and COVID-19 mortality in
the United States: A nationwide cross-sectional study |
| First Case of 2019 Novel
Coronavirus in the United States |
| From
SARS to COVID-19: A previously unknown SARS- related coronavirus
(SARS-CoV-2) of pandemic potential infecting humans – Call for a
OneHealth approach |
| Global Health Concern Stirred by Emerging Viral Infections |
| Interpreting Diagnostic Tests for SARS-CoV-2 |
| Middle East Respiratory Syndrome Coronavirus: Another
Zoonotic Betacoronavirus Causing SARS-Like Disease |
| Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19) |
| Report of the WHO-China
Joint Mission on Coronavirus Disease 2019 (COVID-19) |
| Respiratory
virus shedding in exhaled breath and efficacy of face masks |
| SARS-CoV-2 seroprevalence trends in healthy blood donors during the COVID-19 Milan outbreak |
| SARS-like cluster of circulating bat coronavirus pose threat
for human emergence |
| Severe Acute Respiratory Syndrome Coronavirus as an
Agent of Emerging and Reemerging Infection |
| Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and
the challenges |
| Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo’ |
| TEMPORARY REMOVAL: Experimental Treatment with Favipiravir
for COVID-19: An Open-Label Control Study |
| The 2019‐new coronavirus epidemic: Evidencefor virus
evolution |
| The airborne lifetime of small speech droplets and
their potential importance in SARS-CoV-2 transmission |
| The early phase of the COVID-19 outbreak in Lombardy,
Italy |
| The
proximal origin of SARS-CoV-2 |
| Treatment of 5 Critically Ill Patients With COVID-19
With Convalescent Plasma |
| Understanding
of COVID‐19 based on current evidence |
| Virus - Dalla diffusione
di malattie
letali all’impatto sull’evoluzione della vita, la doppia faccia di
questi microrganismi |
| What
Scientists
Want to Know About the Coronavirus Outbreak |